蒙医温针治疗继发性坐骨神经痛的干预性临床研究

注册号:

Registration number:

ChiCTR-INR-17012175 

最近更新日期:

Date of Last Refreshed on:

2019-10-12 21:38:27 

注册时间:

Date of Registration:

2017-07-29 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

蒙医温针治疗继发性坐骨神经痛的干预性临床研究

Public title:

Mongolian Warm Needling Acupuncture in the Treatment of Secondary Sciatica

注册题目简写:

English Acronym:

研究课题的正式科学名称:

蒙医温针治疗继发性坐骨神经痛的干预性临床研究

Scientific title:

Mongolian Warm Needling Acupuncture in the Treatment of Secondary Sciatica

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

AMCTR-IPC-17000076

申请注册联系人:

包立道 

研究负责人:

阿古拉 

Applicant:

LIDAO BAO 

Study leader:

BO AGULA 

申请注册联系人电话:

Applicant telephone:

+86 15847788800

研究负责人电话:

Study leader's
telephone:

+86 15964539710

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

baolidao237@163.com

研究负责人电子邮件:

Study leader's E-mail:

agula_b@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

呼和浩特通道北街1号内蒙古医科大学附属医院药剂部

研究负责人通讯地址:

呼和浩特金山开发区金山大道内蒙古医科大学

Applicant address:

1 Tongdao Street North, Hohhot, Inner Mongolia Autonomous Region, China

Study leader's address:

Jinshan Avenue, Jinshan Development Area, Hohhot, Inner Mongolia Autonomous Region, China

申请注册联系人邮政编码:

Applicant postcode:

010059

研究负责人邮政编码:

Study leader's postcode:

010110

申请人所在单位:

内蒙古医科大学

Applicant's institution:

Inner Mongolia Medical University

研究负责人所在单位:

内蒙古医科大学

Affiliation of the Leader:

Inner Mongolia Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

YKD2017263

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

内蒙古医科大学医学伦理委员会

Name of the ethic committee:

Inner Mongolia Medical University Medical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2017-07-12 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

内蒙古医科大学

Primary sponsor:

Inner Mongolia Medical University

研究实施负责(组长)单位地址:

呼和浩特通道北街1号内蒙古医科大学附属医院

Primary sponsor's address:

1 Tongdao Street North, Hohhot, Inner Mongolia Autonomous Region, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

内蒙古自治区

市(区县):

Country:

China

Province:

Inner Mongolia Autonomous Region

City:

单位(医院):

内蒙古医科大学

具体地址:

呼和浩特金山开发区金山大道内蒙古医科大学

Institution
hospital:

Inner Mongolia Medical University

Address:

Jinshan Avenue, Jinshan Development Area, Hohhot, Inner Mongolia Autonomous Region, China

经费或物资来源:

内蒙古蒙医药协同创新科研基金

Source(s) of funding:

Inner Mongolia Medicine collaborative innovation research fund

研究疾病:

坐骨神经痛  

Target disease:

Sciatica

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

相对于卧床休息,内服止痛药如芬必得、阿司匹林、保泰松以及肾上腺皮质激素等手段相比,蒙医温针治疗对于坐骨神经痛患者的炎症吸收、神经组织修复具有积极意义。近年来,蒙医温针治疗腰椎间突出所致坐骨神经痛取得了较好的临床疗效。但由于缺乏设计严谨的RCT试验研究,临床研究方法不够完善,使得研究结果的可靠性与论证强度尚未达到应有的信服程度。本研究通过蒙医温针对坐骨神经痛的干预性临床试验来验证其有效性和安全性。  

Objectives of Study:

Compared with bed rest, oral painkillers such as fenbid, aspirin, phenylbutazone and adrenal cortex hormones and other means,Mongolian medical treatment for sciatica patients with inflammatory absorption, nerve tissue repair has a positive meaning. In recent years, Mongolian Warming treatment of lumbar intervertebral herniation caused by sciatica achieved good clinical efficacy. However, due to the lack of rigorous design of RCT test, clinical research methods are not perfect, making the reliability of the results and demonstration strength has not yet reached the degree of convincing. In this study, we examined the efficacy and safety of interferon clinical trials of sclerotinia by Mongolian medicine.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.不符合纳入标准者;2.不合作者,包括不能坚持治疗或加用其他治疗,影响资料收集和疗效评定者;3.孕妇、病情危笃或疾病晚期患者;4.其他不符合内蒙古医科大学医学伦理委员会关于医学临床试验相关规定的。

Exclusion criteria:

1. Those who do not meet the inclusion criteria;
2. Non-co-operatives, including those who can not adhere to treatment or use other treatment, affect the data collection and evaluation of the efficacy of;
3. Pregnant women, critically ill or disease patients;
4. Other do not meet the Inner Mongolia Medical University Medical Ethics Committee on the relevant provisions of medical clinical trials.

研究实施时间:

Study execute time:

From 2017-07-12 00:00:00 To 2019-07-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2017-07-12 00:00:00 To 2019-07-31 00:00:00

干预措施:

Interventions:

组别:

假针灸组

样本量:

50

Group:

Sham acupuncture group

Sample size:

干预措施:

穴位左上角3厘米针刺

干预措施代码:

Intervention:

Acupuncture points is 3 cm left corner

Intervention code:

组别:

蒙医温针组

样本量:

50

Group:

Mongolian warm acupuncture group

Sample size:

干预措施:

温针

干预措施代码:

Intervention:

Warm acupuncture

Intervention code:

组别:

药物组

样本量:

50

Group:

Drug group

Sample size:

干预措施:

布洛芬缓释片

干预措施代码:

Intervention:

Ibuprofen sustained release tablets

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

内蒙古自治区 

市(区县):

 

Country:

China

Province:

Inner Mongolia Autonomous Region

City:

单位(医院):

内蒙古医科大学附属医院 

单位级别:

三级甲等医院 

Institution
hospital:

Affiliated Hospital of Inner Mongolia Medical University

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

Barthel生活功能评价

指标类型:

主要指标

Outcome:

Barthel life function evaluation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

JOA下腰痛评价

指标类型:

主要指标

Outcome:

Evaluation of low back pain in JOA

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

VAPS视觉模拟疼痛评分

指标类型:

主要指标

Outcome:

VAPS visual analogue pain score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

利用SAS 9.2统计学软件生成由150个随机数组成的分组数列。根据性别分层随机。

Randomization Procedure (please state who generates the random number sequence and by what method):

An independent researcher who will not be involved in this research produces 120 random numbers and divides the 120 numbers into 2 allocation sequences using SAS 9.2 software, with one sequence of 75 numbers for male subjects, and the other sequence of 75 numbers for female subjects.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

参与本项目的研究者包括四名针灸师和三名结局指标评估人员。虽然4名针灸师知晓真针灸和假针灸的区别,但是针灸师不能对受试者和评估者透漏治疗分组和治疗效果的信息。三名评估人员对受试者的分组不知情。

Blinding:

Though the 4 acupuncturists can differentiate between real and sham acupuncture, they are not allowed to reveal information about treatment allocation or treatment outcomes to both the subjects and assessors. 3 assessors are blinded to treatment allocation.

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Not stated

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not stated

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Not stated

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Not stated

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2017-07-29 11:13:20